Partnervest Advisory Services’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2020 Q3	$547K	Buy	6,543 +60	+0.9%	+$5.02K	0.17%	104
2020 Q2	$476K	Buy	6,483 +30	+0.5%	+$2.2K	0.18%	100
2020 Q1	$274K	Buy	+6,453	New	+$274K	0.12%	142
2019 Q3	–	Sell	-4,860	Closed	-$229K	–	254
2019 Q2	$229K	Buy	+4,860	New	+$229K	0.09%	187